Clinical findings show association between nadunolimab and lower incidence and later onset of CIPNPreclinical data show prevention of both chemotherapy- and antibody-drug ...

Clinical findings show association between nadunolimab and lower incidence and later onset of CIPNPreclinical data show prevention of ...

Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.

BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health Cohort Study.

CI denotes confidence interval, and LUAD lung adenocarcinoma. Panel D shows age-adjusted logistic-regression analysis for the association between the presence of CHIP and cellular densities ...

Diliman has identified potential biomarkers or signs that can help with early lung cancer detection with the support of the ...